Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Nanoparticles Employed As Lethal Beacons to Kill Tumors

By HospiMedica International staff writers
Posted on 26 Aug 2010
A group of researchers is developing a way to treat cancer by using lasers to light up nanoparticles and destroy tumors with the ensuing heat.

On July 22, 2010, at the 52nd annual meeting of the American Association of Physicists in Medicine (AAPM) in Philadelphia, PA, USA, investigators from Wake Forest University Baptist Medical Center (Winston-Salem, NC, USA) presented their findings on the latest development for this technology: iron-containing, multiwalled carbon nanotubes (MWCNTs), which are 10,000 times thinner than a human hair. More...
In laboratory experiments, the team revealed that by using a magnetic resonance imaging (MRI) scanner, they could image these particles in living tissue, see as they approached a tumor, and target them with a laser, thereby destroying the tumor.

The research builds on an experimental technique for treating cancer called laser-induced thermal therapy (LITT), which uses energy from lasers to heat and destroy tumors. LITT works by virtue of the fact that certain nanoparticles such as MWCNTs can absorb the energy of a laser and then convert it into heat. If the nanoparticles are zapped while within a tumor, they will heat and kill the cancerous cells.

The problem with LITT, however, is that while a tumor may be distinctly visible in a medical scan, the particles are not. They cannot be tracked once injected, which could put a patient in peril if the nanoparticles were zapped away from the tumor because the aberrant heating could destroy healthy tissue.

Now the Wake Forest Baptist researchers have shown for the first time that it is possible to make the particles visible in the MRI scanner to allow imaging and heating at the same time. By loading the MWCNT particles with iron, they become visible in an MRI scanner. Using tissue containing mouse tumors, they showed that these iron-containing MWCNT particles could destroy the tumors when hit with a laser. "To find the exact location of the nanoparticle in the human body is very important to the treatment,” said Xuanfeng Ding, M.S., who presented the research at the meeting. "It is really exciting to watch the tumor labeled with the nanotubes begin to shrink after the treatment.”

An earlier study by the same group showed that laser-induced thermal therapy using a closely related nanoparticle actually increased the long-term survival of mice with tumors. The next step in this project, according to the investigators, is to see if the iron-loaded nanoparticles can do the same thing. If the work proves successful, it may one day help people with cancer, though the technology would have to prove safe and effective in clinical trials.

Related Links:

Wake Forest University Baptist Medical Center




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.